India to Australia: Tobramycin Export Trade Route

The India to Australia Tobramycin corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $1.6M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's tobramycin manufacturing sector.

Across 5 active suppliers, the average shipment value stands at $60.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with tobramycin's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 14.0%, placing it at rank #18 among India's top tobramycin export destinations globally.

On the import side, key buyers of Indian tobramycin in Australia include ALPHAPHARM PTY LTD, SUN PHARMA ANZ PTY LTD, MYLAN AUSTRALIA and 3 others. ALPHAPHARM PTY LTD is the single largest importer with 12 shipments valued at $620.3K USD.

India's tobramycin exports to Australia are driven primarily by a handful of large-scale manufacturers. MYLAN LABORATORIES LIMITED with 17 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MYLAN LABORATORIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED — together account for 95% of total trade value on this route. The average shipment value of $60.6K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as tobramycin sun 300mg/5ml solution for inhalation (tobramycin 300mg/5ml nebulisersolution) [1000 pack x 4x14 =56000 nos]nos and tobramycin sun 300mg / 5 ml solution for , suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ALPHAPHARM PTY LTD is the largest importer with 12 shipments worth $620.3K USD — representing 39% of all tobramycin imports from India on this route. A total of 6 buyers are active on this corridor.